MFG
LRMR icon

Merit Financial Group’s Larimar Therapeutics LRMR Stock Holding History

Merit Financial Group’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.3K Buy
+10,254
New +$40.7K ﹤0.01% 2318

Other funds holding LRMR

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CSP
Cary Street Partners Richmond, Virginia $4.58B AUM 24% 1-Year Est. Return
NLP
Next Level Private Harrison, New York $511M AUM 30.94% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return
PWA
Physician Wealth Advisors Midvale, Utah $837M AUM 26% 1-Year Est. Return

Merit Financial Group's LRMR Position: Q2 2026 in Review

Merit Financial Group opened a new position in Larimar Therapeutics (LRMR) in Q2 2026: 10,254 shares worth $31.3K. The stake represents ﹤0.01% of the portfolio and ranks #2318 among its holdings.

11 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.

  • Merit Financial Group held 10,254 shares of Larimar Therapeutics worth $31.3K as of Q2 2026.
  • Larimar Therapeutics was a new Merit Financial Group position in Q2 2026.
  • Larimar Therapeutics made up ﹤0.01% of Merit Financial Group's portfolio in Q2 2026, its #2318 holding.
  • 11 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.

Based on Merit Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.